Found 2795 related files. Current in page 1
Yet somehow best suited look is significant, seeing as free of successful fashion these buyers who observe your web site leaves prior to it all designs internet. The particular typical web site a good deal located in 24 a while around 28th.12, and then the standard reader stays put for a site designed for 37 the least bit, clearly plenty of depart from right before typically the site surface finishes launching. We can determine from the.
We are a time served 24 hour locksmith in the edinburgh and lothians area that can guarantee a high quality standard of work carried out at competitave rates by trustworthy reliable engineers
FLEXIBLE HOSE DATA SHEET EASYFLEX Flexible Sprinkler Drops are designed to significantly reduce labor and installation costs. By eliminating the need for pipe cutting and midline connections, you save valuable time and money. EASYFLEX Flexible Sprinkler Drops can be installed on almost any suspended commercial ceilings. The ﬂexible hose allows for fast installation while our innovative brackets are simple and easy to install. Brackets for T-Bar ceiling grids, wall mount, metal studs, woodbeams, open hat channels, industrial ducts, and cleanrooms. No special tools required, and installation completed in a few easy steps. Flexible hoses come in braided or unbraided types, from 24” to 72” in length. EASYFLEX Flexible Sprinkler Drops Appliance Standards National Fire Protection Association (NFPA): - NFPA 13: Standard for the Installation of Sprinkler Systems - NFPA 13D: Standard for the Installation of Sprinkler Systems in One and Two-Family Dwellings and Manufactured Homes - NFPA 13R: Standard for Installation of Sprinkler Systems in residential Occupancies up to and including four stories in height American Society for Testing and Methods (ASTM): - ASTM C635: Standards speciﬁcations for the manufacture, performance, and testing of metal suspension systems for acoustical tile and lay-in panel ceilings...
These characteristics should be a given with any manufacturer of hose assemblies. Flexible Components of Saint-Gobain Performance Plastics meets — indeed, greatly exceeds — these fundamental standards. As this catalog makes clear, innovative engineering and close attention to the issues facing those who use our products set Flexible Components hose assemblies apart from all others on the market. Our Chemfluor® fluoropolymer extruded tubing — the foundation of all our hose products — sets the industry standard for chemical and corrosion resistance, ease of use, and compliance with all key industry standards. Our S.I.B.® (Smooth Inner Bore) technology provides a totally seamless transition between hose and fitting, virtually eliminating the problems caused by particle entrapment in standard barb assemblies and simplifying maintenance. Our unique Flare-Thru fitting design ensures that the material being conveyed contacts only pure, non-contaminating Chemfluor® fluoropolymer tubing from end to end. Everything we do at Flexible Components is based on one simple premise: We want our hose and fitting products to be best in class. We believe the many customers who swear by our products are the most compelling proof of the success of this single-minded focus.
SAMPLE RESUME FORMAT Although the Federal Government does not require a standard application form for most jobs, we do need certain information to evaluate your qualifications and determine if you meet legal requirements for Federal employment. If your resume or application does not provide all the information requested in the job vacancy announcement you may lose consideration for a job. WHAT TO INCLUDE Job Information Announcement number, title and grade of the job you are applying for Personal Information Full name, mailing address (with Zip Code) Day and Evening phone numbers Email Country of Citizenship Veterans’ Preference Reinstatement eligibility (Proof of your career or career conditional status may be requested) Highest Federal civilian grade held (provide job series and dates held) Desired Location(s) Work Experience Provide information for your paid and nonpaid work experience related to the job you are applying for. Job Title (include series and grade if Federal job) Job Address Duties and accomplishments Employer’s name and address Starting and ending dates (month and year) Hours per week Salary Supervisor’s name and phone number Indicate if we may contact your current supervisor. Education High School o Name, City, and State o Date of diploma or GED Colleges or Universities o Majors o Name, City, and State o Type and year of any degrees received o If no degree, show total credits earned and indicate whether semester or quarter hours.) A copy of your college transcript may be requested if you are using education to meet qualification requirements. An official transcript will be required prior to your appointment if selected.
Satisfy Professional's Needs Chain Saw UC3020A / UC3520A / UC4020A 300mm (12") 350mm (14") 400mm (16") Designed with the concept of "Easy Operation and Maintenance" Rubberized Soft Rear Grip Toolless Blade Change and Adjustment Large View Window of Oil Tank Ergonomically Positioned and Angled Front Grip Flat External Design Metal Spike Bumper Provides increased stability in tool maintenance such as oiling/blade change. Powerful Cutting Thanks to the High Torque Delivered by Heavy-Duty 1,800 W Motor. Chain Saw UC3020A 300mm (12") / UC3520A 350mm (14") / UC4020A 400mm (16") 132 Double Insulation Electric Brake Automatic Oiling Chain Brake Specification Continuous rating Input Chain speed per minute Guide bar length Chain Blade Dimensions (L x W x H) Net weight Power supply cord Standard equipment UC3020A UC3520A UC4020A 1,800W 800m (2,620ft) 300mm (12") pitch : 3/8" gauge : 0.050" 417 x 245x 198mm (19-3/8" x 9-5/8" x 7-3/4" ) 3.7kg (8.2lbs) 0.3m (0.98ft) 1,800W 800m (2,620ft) 350mm (14") pitch : 3/8" gauge : 0.050" 417 x 245x 198mm (19-3/8" x 9-5/8" x 7-3/4" ) 3.7kg (8.2lbs) 0.3m (0.98ft) 1,800W 800m (2,620ft) 400mm (16") pitch : 3/8" gauge : 0.050" 417 x 245x 198mm (19-3/8" x 9-5/8" x 7-3/4" ) 3.7kg (8.2lbs) 0.3m (0.98ft) Chain Blade, Guide Bar Scabbard, Hook completed Dimensions and Net weight : excluding blade and guide bar Items of standard equipment and specifications may differ from country to country.
August 2013 Patient Advisory for Stem Cell Therapy and Medical Tourism As stakeholders in cellular therapy, the undersigned professional organizations believe it is necessary to share the following important message with patients and families contemplating cell therapy or experimental stem cell procedures. In this document, best practices are outlined to assist patients and family members in their healthcare decisions. Controlled innovation in the context of patient safety is paramount as potential therapeutic products or procedures are researched, tested, advanced and proven. Our organizations have received questions and concerns from patients and this document presents an opportunity to address them. Introduction Advancement of clinical therapies is best done in the setting of rigorous and formal clinical trials and in a structured regulatory framework. This helps assure that safety considerations, professional peer review, and the management of patient rights and obligations are considered and addressed. Some procedures would be considered standard of care, because scientific studies have shown that they are safe and effective. Not all procedures offered to patients in all regions of the world are tested in this manner and not all geographical regions have regulations for cellular therapies or patient protection. Additionally, it is possible that some practitioners may offer stem cell procedures without following the existing regulations. Patients may be seeking treatment for incurable, potentially untreatable diseases and may be susceptible to false promises or may not have access to all of the information needed to make this important decision. As patients and families contemplate voluntarily ...
Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers Grafix closes three times as many wounds as standard of care - the largest relative improvement ever reported in a multi-center, randomized, controlled clinical trial for DFU COLUMBIA, Md. - August 13,2013 - Osiris Therapeutics, Inc. (NASDAQ: OSIR), reported today that its multicenter, randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to standard of care in patients with chronic diabetic foot ulcers had met the pre-specified stopping rules for overwhelming efficacy as determined by the data monitoring committee during a planned interim analysis. For the primary endpoint, 62% of patients receiving Grafix had complete wound closure compared to only 21% (p<0.0001) of patients who received conventional treatment for their wounds - a relative improvement of 191% and the largest ever reported from such a study. A total of 131 patients were enrolled with the interim analysis being conducted on the first 97 to complete the trial. The trial also reached statistical significance in favor of Grafix on all top-line secondary endpoints, demonstrating faster wound closure and a reduction in the number of treatments needed to achieve wound closure. In the crossover phase of the trial, patients whose wounds failed to close after 12 weeks of standard of care had an 80% closure rate when switched to Grafix. Importantly, patients randomized to receive standard of care were 74% more likely to experience an adverse event than those receiving Grafix (p=0.008). As a result, the blinded phase of the trial is being discontinued immediately and all patients randomized to the control arm will be offered treatment with Grafix. “Today, Osiris has established a new standard in diabetic wound care and has demonstrated to the world the tremendous impact stem cell products can have in medicine,” said C. Randal Mills, Ph.D., Chief Executive Officer. “Diabetic foot ulcers afflict 25% of all diabetics and are responsible for more hospitalizations than any other diabetic complication. With 25 million diabetics in the United States, the cost to our health care system is enormous. Through this rigorous study we have shown that Grafix can heal more patients, in less time, and with fewer complications.”
Mac Category MacBook Air MD223LL/A MD224LL/A MD231LL/A MD232LL/A MacBook Pro MD101LL/A MacBook Air 11-inch: 64GB 1.7GHz dual-core Intel Core i5 processor, Turbo Boost up to 2.6GHz 4GB memory 64GB flash storage Intel HD Graphics 4000 MacBook Air 11-inch: 128GB 1.7GHz dual-core Intel Core i5 processor, Turbo Boost up to 2.6GHz 4GB memory 128GB flash storage Intel HD Graphics 4000 MacBook Air 13-inch: 128GB 1.8GHz dual-core Intel Core i5 processor, Turbo Boost up to 2.8GHz 4GB memory 128GB flash storage Intel HD Graphics 4000 MacBook Air 13-inch: 256GB 1.8GHz dual-core Intel Core i5 processor, Turbo Boost up to 2.8GHz 4GB memory 256GB flash storage Intel HD Graphics 4000 Contract Price $949.00 Standard List Contract Savings $999.00 $50.00 $1,049.00 $1,099.00 $50.00 $1,149.00 $1,199.00 $50.00 $1,349.00 $1,399.00 $50.00 Contract Price $1,099.00 Standard List Contract Savings $1,199.00 $100.00 MD212LL/A ME662LL/A ME664LL/A ME665LL/A BJ075LL/A BJ248LL/A BJ250LL/A BJ251LL/A MacBook Pro 13-inch 2.5GHz Dual-core Intel Core i5, Turbo Boost up to 3.1GHz 4GB 1600MHz memory 500GB 5400-rpm hard drive Intel HD Graphics 4000 Built-in battery (7 hours) MacBook Pro 13-inch 2.9GHz Dual-core Intel Core i7, Turbo Boost up to 3.6GHz 8GB 1600MHz memory 750GB 5400-rpm hard drive Intel HD Graphics 4000 Built-in battery (7 hours) MacBook Pro 15-inch 2.3GHz Quad-core Intel Core i7, Turbo Boost up to 3.3GHz 4GB 1600MHz memory 500GB 5400-rpm hard drive Intel HD Graphics 4000 NVIDIA GeForce GT 650M with 512MB of GDDR5 memory Built-in battery (7 hours) MBP 13.3/2.5/8GB/128GB FLASH MBP 13.3/2.6/8GB/256GB FLASH MBP 15.4/2.4/8GB/256GB FLASH MBP 15.4/2.7/16GB/512GB FLASH BNDL MBP 13.3/2.5/8G/128GB FLASH APP BNDL MBP 13.3/2.6/8GB/256GBFlash APP BNDL MBP 15.4/2.4/8GB/256GBFlash APP BNDL MBP15.4/2.7/16GB/512GBFlash APP Mac mini MD387LL/A MD388LL/A MD389LL/A MAC MINI 2.5 DC/2X2G/500G/AP/BT MAC MINI 2.3 QC/2X2G/1TB/AP/BT MAC MINI 2.3 QC/2X2G/2X1TB/AP/BT/SVR Contract Price $579.00 $779.00 $979.00 Standard List Contract Savings $599.00 $20.00 $799.00 $20.00 $999.00 $20.00 iMac MD093LL/A MD094LL/A MD095LL/A MD096LL/A
course of the investigation. On December 1, 2013, about 0719 eastern standard time, southbound Metro-North Railroad (Metro-North) passenger train number 8808 derailed at milepost 11.35 on track number 2 of the Metro-North Hudson Line in The Bronx, New York. Train movements on this line are governed by a traffic control system. The train originated in Poughkeepsie, New York with a destination of Grand Central Station in New York City. It consisted of seven passenger cars and one locomotive at the rear pushing the train. As a result of the derailment, 4 passengers died and 59 persons were transported to local hospitals for injuries. Metro-North estimated there were about 115 passengers on the train at the time of the derailment. Damage was estimated by Metro-North to be in excess of $9 million. The weather at the time of the accident was reported as 39° F with cloudy skies. Figure: Aerial view of accident scene National Transportation Safety Board (NTSB) investigators have completed the on-scene work in The Bronx. The investigation will continue at the NTSB headquarters in Washington, D.C. Preliminary results of the investigation include: The derailment occurred in a 6 degree left hand curve where speed was limited to 30 mph. Estimated train speed at the time of the derailment was at 82 mph. Detailed inspection and testing of the signal system, train brakes, and other mechanical equipment did not identify any anomalies. An inspection of the track in the derailment area did not identify any pre-accident anomalies. All cars on the train and the locomotive derailed. Between December 1 and 11, 2013, investigators completed interviews of train crews and first responders. Interview transcripts will be included in the public docket upon release. Locomotive event recorders were sent to the NTSB laboratory in Washington, D.C. for further analysis. The parties to the investigation include the Federal Railroad Administration, Metro-North Railroad, New York Public Transportation Safety Board, Teamsters Local 808, New York Police Department, New York Fire Department, and Bombardier Transportation. The Association of Commuter Rail Employees (ACRE) was initially designated as a party. However, because one of ACRE’s senior officials made unauthorized comments on the investigation to the media, ACRE was removed as a party on December 3, 2013.